Cardiovascular Diabetology | Most Viewed

Submit a manuscript Register Contact us Follow
BioMed Central Support

Explore journal

Advertisement

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 48161 Accesses	Review Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate Melvin R Hayden, Suresh C Tyagi, Lisa Kolb, James R Sowers, Ramesh Khanna Cardiovascular Diabetology 2005, 4:4 (18 March 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	2. 42555 Accesses	Review How hyperglycemia promotes atherosclerosis: molecular mechanisms Doron Aronson, Elliot J Rayfield Cardiovascular Diabetology 2002, 1:1 (8 April 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	3. 40608 Accesses	Review Endothelial dysfunction: a comprehensive appraisal Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón, Rogelio A Machado Cardiovascular Diabetology 2006, 5:4 (23 February 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	4. 33974 Accesses	Review Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice Jeanette Johansen, Alex K Harris, David J Rychly, Adviye Ergul Cardiovascular Diabetology 2005, 4:5 (29 April 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	5. 30859 Accesses	Review Influence of diabetes mellitus on heart failure risk and outcome Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire, Pascal de Groote Cardiovascular Diabetology 2003, 2:1 (8 January 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	6. 30182 Accesses	Review Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2002, 1:3 (27 September 2002) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	7. 28803 Accesses	Review Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR) Alexander Tenenbaum, Enrique Z Fisman, Michael Motro Cardiovascular Diabetology 2003, 2:4 (23 March 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	8. 25517 Accesses	Original investigation Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study Giuseppe MC Rosano, Cristiana Vitale, Barbara Sposato, Giuseppe Mercuro, Massimo Fini Cardiovascular Diabetology 2003, 2:16 (28 November 2003) Abstract \| Full text \| PDF \| PubMed
	9. 23173 Accesses	Original investigation Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, Anita Hansson, Margareta Söderström, Staffan Lindeberg Cardiovascular Diabetology 2009, 8:35 (16 July 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	10. 20906 Accesses	Hypothesis Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2003, 2:2 (12 February 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	11. 20906 Accesses	Original investigation Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study Arya M Sharma, Jaime Davidson, Stephen Koval, Yves Lacourcière Cardiovascular Diabetology 2007, 6:28 (2 October 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	12. 20856 Accesses	Original investigation Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome Cristiana Vitale, Giuseppe Mercuro, Carlotta Castiglioni, Alessandra Cornoldi, Arianna Tulli, Massimo Fini, Maurizio Volterrani, Giuseppe MC Rosano Cardiovascular Diabetology 2005, 4:6 (15 May 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 20354 Accesses	Original investigation Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study Christian Berne, Annica Siewert-Delle, the URANUS study investigators Cardiovascular Diabetology 2005, 4:7 (3 June 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	14. 18957 Accesses	Original investigation Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481] The FIELD Study Investigators Cardiovascular Diabetology 2005, 4:13 (22 August 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	15. 18151 Accesses	Case Report Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:1 (4 January 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	16. 18142 Accesses	Original investigation Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom Anette Woehl, Mark Evans, Anthony P Tetlow, Philip McEwan Cardiovascular Diabetology 2008, 7:24 (11 August 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	17. 17851 Accesses	Review Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2004, 3:1 (4 February 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	18. 17257 Accesses	Review Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins Alexander Tenenbaum, Enrique Z Fisman, Michael Motro, Yehuda Adler Cardiovascular Diabetology 2006, 5:20 (26 September 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 16277 Accesses	Commentary Losartan and diabetic nephropathy: commentaries on the RENAAL study Enrique Z Fisman, Alexander Tenenbaum, Michael Motro Cardiovascular Diabetology 2002, 1:2 (8 April 2002) Abstract \| Full text \| PDF \| PubMed
	20. 15880 Accesses	Review The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded Melvin R Hayden, James R Sowers, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:9 (28 June 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	21. 15487 Accesses	Original investigation Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study Osamu Ogawa, Tomio Onuma, Sayaka Kubo, Naomi Mitsuhashi, Chie Muramatsu, Ryuzo Kawamori Cardiovascular Diabetology 2003, 2:10 (28 August 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	22. 14263 Accesses	Review Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons Alexander Tenenbaum, Michael Motro, Enrique Z Fisman Cardiovascular Diabetology 2005, 4:14 (16 September 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| 1 comment
	23. 13755 Accesses	Original investigation Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study Luis Cea-Calvo, Pedro Conthe, Pablo Gómez-Fernández, Fernando de Alvaro, Cristina Fernández-Pérez, RICARHD investigators Cardiovascular Diabetology 2006, 5:23 (3 November 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	24. 12971 Accesses	Original investigation The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481] The FIELD Study Investigators Cardiovascular Diabetology 2004, 3:9 (1 December 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	25. 12458 Accesses	Review Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties Edite Teixeira-Lemos, Sara Nunes, Frederico Teixeira, Flávio Reis Cardiovascular Diabetology 2011, 10:12 (28 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central